13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q2 2024 · Filed August 14, 2024 · Accession 0000919574-24-004535
Total Value
$19.7M
Positions
12
Other Managers
0
Confidential Omitted
Yes
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | XERIS BIOPHARMA HOLDINGS INC | XERS | 5,113,348 | $11.5M | 58.31% |
| 2 | REZOLUTE INC | RZLT | 1,318,967 | $5.7M | 28.74% |
| 3 | SPDR S&P 500 ETF TR | SPY | 1,869 | $1.0M | 5.15% |
| 4 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 1,025 | $417,070 | 2.11% |
| 5 | LEXEO THERAPEUTICS INC | LXEO | 17,851 | $286,331 | 1.45% |
| 6 | MIND MEDICINE INC | 60255C885 | 30,383 | $219,059 | 1.11% |
| 7 | ABIVAX SA | AAVXF | 13,900 | $183,760 | 0.93% |
| 8 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $172,359 | 0.87% |
| 9 | MOLECULAR TEMPLATES INC | 608550208 | 136,866 | $157,396 | 0.80% |
| 10 | COMPASS THERAPEUTICS INC | CMPX | 43,465 | $43,465 | 0.22% |
| 11 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $36,899 | 0.19% |
| 12 | ADICET BIO INC | ACET | 17,488 | $21,160 | 0.11% |